SNYDER DAVID S 4
4 · Coya Therapeutics, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
SNYDER DAVID S
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-31+81,819→ 81,819 totalExercise: $5.90Exp: 2034-01-31→ Common Stock (81,819 underlying)
Footnotes (1)
- [F1]The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.